Hasil Pencarian
	Ditemukan 935 dokumen dengan kata kunci 4740 Simpan CSV  Pertuzumab: new hope for patients with HER2-positive breast cancer No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.273–282 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2278-2284 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1841-1847 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1526-1533 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1740-1748 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2- positive metastatic breast cancer pretreated with anti- HER2 therapy No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.109-116 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.101-108 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.661-668 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2005-20011 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.1999-2004 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prev   1 2 3 4 5 6 7 8 9 10  Next